December MIMS Update

Some of the recent changes to the medicines landscape, with new products and indications  New Products Bretovameran (Comirnaty JN.1) is a nucleoside-modified messenger RNA formulated in lipid nanoparticles, which enable delivery of the non-replicating RNA into host cells to direct transient expression of the SARS-CoV-2 spike (S) antigen. Comirnaty elicits both neutralising antibody and cellular